The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades Long pursuit of common mutation appears to be paying off for patients and for Revolution Medicines

https://www.statnews.com/2026/04/19/daraxonrasib-pancreatic-cancer-kras-revolution-medicines-patient-story/ By Angus ChenApril 19, 2026 Angus Chen angus.chen@statnews.com